Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib

BACKGROUND: There are no validated markers that predict response in metastatic renal cell cancer (RCC) patients treated with sunitinib. We aim to study the impact of single-nucleotide polymorphisms (SNPs) that have recently been proposed as predictors of outcome to anti-VEGF-targeted therapy in meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Beuselinck, B, Karadimou, A, Lambrechts, D, Claes, B, Wolter, P, Couchy, G, Berkers, J, Paridaens, R, Schöffski, P, Méjean, A, Verkarre, V, Lerut, E, de la Taille, A, Tourani, J-M, Bigot, P, Linassier, C, Négrier, S, Berger, J, Patard, J-J, Zucman-Rossi, J, Oudard, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590652/
https://www.ncbi.nlm.nih.gov/pubmed/23462807
http://dx.doi.org/10.1038/bjc.2012.548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590652/
https://www.ncbi.nlm.nih.gov/pubmed/23462807
http://dx.doi.org/10.1038/bjc.2012.548

Ejemplares similares